Reshaping the Insurance Balance Sheet
Disposals and stake exchanges, and in one case a reinsurance cession, are being used to change what insurance groups keep on their balance sheets.
- Status: Emerging
- Medium confidence
- Demonstration
Thesis
Groups in the records here are taking parts of their balance sheets out: Aegon has exchanged its Dutch business for cash and a minority stake and agreed to do the same with its UK business, and L&G has sold its US protection business, generating GBP 1.2 billion of Solvency II capital. Prudential has ceded in-force reserves to a co-sponsored vehicle, though the release gives no capital effect. Our thesis is that stake exchanges and disposals are being used as capital tools, not only to exit businesses. The evidence is a handful of transactions, not a measured shift across the industry.
Evidence
Supporting
Transaction · Aegon · 4 July 2023
Aegon completes transaction with a.s.r.
SupportsAn operating business exchanged for cash and a minority stake.
Transaction · Aegon · 15 April 2026
Aegon to sell Aegon UK to Standard Life
SupportsThe same structure agreed in 2026 with Aegon UK and Standard Life.
Transaction · Legal & General · 7 February 2025
SupportsThe sale of L&G's US protection business to Meiji Yasuda, with Meiji Yasuda taking a 20% economic interest in L&G's US pension risk transfer business.
Transaction · Legal & General · 2 February 2026
L&G completes transaction with Meiji Yasuda
SupportsCompletion generating GBP 1.2 billion of Solvency II capital, with GBP 1.0 billion of the proceeds planned for an additional buyback.
Transaction · Prudential Financial (investor relations) · 5 October 2026
Prismic Life announces USD 5 billion reinsurance agreement with Prudential Financial
SupportsIn-force reserves moved to a reinsurance vehicle co-sponsored with private capital; the release gives no capital effect, so this is context rather than support for the capital-tool reading.
Counter-evidence
No counter-evidence recorded yet. Its absence is a gap, not a finding.
What would change the view
- The groups' disclosures show negligible solvency or capital effects from these transactions, with risk reduction or exit given as the rationale.
- Capital generated or released is below 10% of the transaction value in the deals where it is disclosed.
Implications
Capital implication
Released capital is returned or redeployed now, while the earnings of what was sold or ceded are given up later.
Strategic implication
Groups keep a narrower set of earnings sources, so results depend more on the businesses retained; Aegon's US ambition is the test case.
Companies affected
Related signals
Capital and investments
Prudential Financial
Prudential Financial cedes USD 5 billion of Japanese whole life reserves to its Prismic sidecar
- Reported
- On 5 October 2026 Prismic Life, sponsored by Prudential Financial and Warburg Pincus, announced that it will reinsure approximately USD 5 billion of reserves backing USD-denominated Japanese whole life policies originated by Prudential's Japanese affiliates. The release states that Prudential's obligations to these policyholders remain unchanged, and that with the closing of the transaction Prismic manages approximately USD 25 billion of assets supporting assumed liabilities.
- Our interpretation · working hypothesis
- Ceding about USD 5 billion of reserves to a vehicle Prudential co-sponsors may let it reduce the capital held against a long-duration, dollar-denominated Japanese block while keeping the policyholder relationship and, through its sponsorship, some share of the economics. If so, the structure releases capital without exiting the block. Whether it works depends on what the release does not disclose: how much capital Prudential releases, and how much of the block's future profit now goes to outside investors.
- Balance Sheet · The Convergence with Private Capital · Capital Management
- Medium confidence
- Demonstration
Strategy and business model
Aegon
Aegon agrees to sell Aegon UK to Standard Life for cash and a 15.3% stake
- Reported
- On 15 April 2026 Aegon announced it will sell Aegon UK to Standard Life for a total consideration of GBP 2.0 billion: a 15.3% shareholding (181.1 million shares) in Standard Life plc and GBP 0.75 billion in cash. The transaction is expected to close around the end of 2026, subject to customary conditions including regulatory approvals, and the cash is expected to be used for deleveraging and share buy-backs once completed. Aegon describes it as a step in its ambition to become a leading US life insurance and retirement group.
- Our interpretation · working hypothesis
- As with a.s.r. in 2023, Aegon is exchanging an operating business for cash plus a minority stake: about GBP 1.25 billion of the GBP 2.0 billion comes as a 15.3% stake in Standard Life, which keeps economic exposure to the UK business while control of it, and its growth and capital decisions, pass to Standard Life. Aegon gives up the UK unit's own capital generation in return for GBP 0.75 billion in cash, which it says it will use for deleveraging and buybacks, and its share of the earnings of a company it does not control. That concentrates its operating risk on the United States, so whether shareholders gain depends on returns there, not on the sale itself.
- M&A · Balance Sheet · Ownership & Control
- High confidence
- Demonstration
Strategy and business model
L&G
Legal & General sells its US insurance entity to Meiji Yasuda
- Reported
- Legal & General announced on 7 February 2025 the sale of its US insurance entity to Meiji Yasuda at an equity value of USD 2.3 billion, and completed it on 2 February 2026. Meiji Yasuda takes the US protection business and a 20% economic interest in L&G's US pension risk transfer business, and will acquire a 5% economic interest in L&G. L&G said the transaction generates GBP 1.2 billion of Solvency II capital and brings its planned 2026 share buyback to GBP 1.2 billion.
- Our interpretation · working hypothesis
- L&G is selling a business outside its stated core for cash proceeds, and plans to use GBP 1.0 billion of them for an additional buyback. Planning to return more than half of the proceeds is consistent with L&G's stated plan to return about 40% of its market capitalisation over 2025 to 2027, and it means most of the proceeds go to shareholders rather than into growing the businesses L&G keeps. The cost is the protection earnings L&G gives up, and a US pension risk transfer business in which Meiji Yasuda now holds a 20% economic interest.
- M&A · Capital Management · Shareholder Returns & Capital Allocation
- High confidence
- Demonstration
Strategy and business model
AXA
AXA separates owning an asset manager from controlling its investments
- Reported
- AXA completed the sale of AXA Investment Managers to BNP Paribas on 1 July 2025, for cash proceeds of EUR 5.1 billion. Under a long-term partnership, BNP Paribas provides investment management services to AXA. AXA states that it retains full authority over product design, asset allocation and asset-liability management decisions.
- Our interpretation · working hypothesis
- The structure is consistent with treating the value for an insurer as lying in how its balance sheet is invested, not in owning the firm that carries out those decisions. AXA keeps authority over asset allocation and asset-liability management, converts the manager into EUR 5.1 billion of proceeds, whose use the announcement does not set out, and gives up the asset-management margin, depending instead on an external manager under a long-term contract whose fee and performance terms are not disclosed. The fees AXA pays BNP Paribas, and its investment expenses after the sale, are the test.
- The Convergence with Private Capital · M&A · Capital Management
- High confidence
- Demonstration
Strategy and business model
Aegon
Aegon converts its Dutch operations into a stake in a.s.r.
- Reported
- On 4 July 2023 Aegon completed the combination of its Dutch pension, life and non-life insurance, banking and mortgage origination activities with a.s.r., receiving EUR 2.2 billion in cash and a 29.99% stake in a.s.r. Aegon said it expected to start a EUR 1.5 billion share buyback shortly.
- Our interpretation · working hypothesis
- Aegon turned a Dutch business it controlled into EUR 2.2 billion of cash and a 29.99% minority stake, giving up control of capital allocation and growth in the Netherlands while keeping a share of the earnings through a.s.r. It said it expected to start a EUR 1.5 billion buyback, equal in size to about two-thirds of the cash received, which suggests most of the cash is going to shareholders rather than into the businesses Aegon kept. Whether dividends from the a.s.r. stake replace what the Dutch business contributed to the group is the test of what the exchange cost.
- M&A · Balance Sheet · Capital Management
- High confidence
- Demonstration